Allurion Technologies (ALURW) Cash from Financing Activities (2022 - 2026)

Allurion Technologies (ALURW) reported Cash from Financing Activities of $2.9 million for Q1 2026, down 80.23% on a YoY basis from $14.5 million in Q1 2025, and down 37.65% quarter-over-quarter from $4.6 million in Q4 2025.

Allurion Technologies (ALURW) Cash from Financing Activities (2022 - 2026) Analysis & Trends

Allurion Technologies has reported Cash from Financing Activities for 5 years, with the latest figure at $2.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities fell 80.23% year-over-year to $2.9 million; the trailing twelve-month figure through Mar 2026 stood at $7.3 million (down 78.62% YoY), and the FY2025 full-year result was $19.0 million, down 6.13% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $2.9 million, down from $4.6 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $98.9 million in Q3 2023, with the low at -$20.4 million in Q4 2023.
  • Historically, Cash from Financing Activities has averaged $10.8 million across 5 years, with a median of $4.6 million in 2025.
  • Annual changes were most pronounced in 2023 — Cash from Financing Activities tumbled 239.4% — and 2025, when it surged 8773.58%.
  • Allurion Technologies' Cash from Financing Activities stood at $14.6 million in 2022, then plunged by 239.4% to -$20.4 million in 2023, then jumped by 99.74% to -$53000.0 in 2024, then surged by 8773.58% to $4.6 million in 2025, then slumped by 37.65% to $2.9 million in 2026.
  • The last three Cash from Financing Activities figures came in at $2.9 million (Q1 2026), $4.6 million (Q4 2025), and -$55000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 17.31 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -1.51 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -451.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -25.00 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 21.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -97.90 Mn
10 Allurion Technologies - - 1.23 Mn 2.87 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.87 Mn
Mar 31, 2026 2.87 Mn
Dec 31, 2025 4.60 Mn
Dec 31, 2025 4.60 Mn
Sep 30, 2025 -55,000.00
Sep 30, 2025 -55,000.00
Jun 30, 2025 -71,000.00
Jun 30, 2025 -71,000.00
Mar 31, 2025 14.50 Mn
Mar 31, 2025 14.50 Mn
Dec 31, 2024 -53,000.00
Dec 31, 2024 -53,000.00
Sep 30, 2024 20.93 Mn
Sep 30, 2024 20.93 Mn
Jun 30, 2024 -1.06 Mn
Jun 30, 2024 -1.06 Mn
Mar 31, 2024 387,000.00
Mar 31, 2024 387,000.00
Dec 31, 2023 -20.41 Mn
Dec 31, 2023 -20.41 Mn